Cargando…

Targeting Mitochondria by SS-31 Ameliorates the Whole Body Energy Status in Cancer- and Chemotherapy-Induced Cachexia

SIMPLE SUMMARY: Cancer cachexia is a debilitating syndrome, caused by both tumor growth and chemotherapy. The skeletal muscle is one of the main tissues affected during cachexia, presenting with altered metabolism and function, leading to progressive tissue wasting. In the current study we aimed at...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ballarò, Riccardo, Lopalco, Patrizia, Audrito, Valentina, Beltrà, Marc, Pin, Fabrizio, Angelini, Roberto, Costelli, Paola, Corcelli, Angela, Bonetto, Andrea, Szeto, Hazel H., O’Connell, Thomas M., Penna, Fabio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923037/ https://www.ncbi.nlm.nih.gov/pubmed/33670497 http://dx.doi.org/10.3390/cancers13040850

Ejemplares similares

Mitochondrial Dysfunction in Cancer Cachexia: Impact on Muscle Health and Regeneration
por: Beltrà, Marc, et al.
Publicado: (2021)

The Skeletal Muscle as an Active Player Against Cancer Cachexia
por: Penna, Fabio, et al.
Publicado: (2019)

Moderate Exercise Improves Experimental Cancer Cachexia by Modulating the Redox Homeostasis
por: Ballarò, Riccardo, et al.
Publicado: (2019)

Modulating Metabolism to Improve Cancer-Induced Muscle Wasting
por: Penna, Fabio, et al.
Publicado: (2018)

SS-31, a Mitochondria-Targeting Peptide, Ameliorates Kidney Disease
por: Zhu, Yuexin, et al.
Publicado: (2022)

Cachexia induced by cancer and chemotherapy yield distinct perturbations to energy metabolism
por: Pin, Fabrizio, et al.
Publicado: (2019)

Treatment with Soluble Activin Receptor Type IIB Alters Metabolic Response in Chemotherapy-Induced Cachexia
por: O’Connell, Thomas M., et al.
Publicado: (2019)

Poster 100: Evaluation of SS-31 as a Potential Therapeutic in the Treatment of Tendinopathy
por: Szeto, Hazel, et al.
Publicado: (2022)

Metabolic Biomarkers for the Early Detection of Cancer Cachexia
por: O’Connell, Thomas M., et al.
Publicado: (2021)

PGC-1α in the myofibers regulates the balance between myogenic and adipogenic progenitors affecting muscle regeneration
por: Beltrà, Marc, et al.
Publicado: (2022)

Evaluation of SS-31 as a Potential Therapeutic Target in the Treatment of Tendinopathy
por: Szeto, Hazel, et al.
Publicado: (2020)

Are there any benefits of exercise training in cancer cachexia?
por: Argilés, Josep M., et al.
Publicado: (2012)

The mitochondria-targeted peptide SS-31 binds lipid bilayers and modulates surface electrostatics as a key component of its mechanism of action
por: Mitchell, Wayne, et al.
Publicado: (2020)

Beneficial effects of SS-31 peptide on cardiac mitochondrial dysfunction in tafazzin knockdown mice
por: Russo, Silvia, et al.
Publicado: (2022)

Combined approach to counteract experimental cancer cachexia: eicosapentaenoic acid and training exercise
por: Penna, Fabio, et al.
Publicado: (2011)

Interference with Ca(2+)-Dependent Proteolysis Does Not Alter the Course of Muscle Wasting in Experimental Cancer Cachexia
por: Pin, Fabrizio, et al.
Publicado: (2017)

Vitamin D and VDR in cancer cachexia and muscle regeneration
por: Camperi, Andrea, et al.
Publicado: (2017)

Toxicity of Neurons Treated with Herbicides and Neuroprotection by Mitochondria-Targeted Antioxidant SS31
por: Reddy, Tejaswini P., et al.
Publicado: (2011)

Combined Therapy with SS31 and Mitochondria Mitigates Myocardial Ischemia-Reperfusion Injury in Rats
por: Lee, Fan-Yen, et al.
Publicado: (2018)

Humoral mediation for cachexia in tumour-bearing rats.
por: Tessitore, L., et al.
Publicado: (1993)

Coupled TLC and MALDI-TOF/MS Analyses of the Lipid Extract of the Hyperthermophilic Archaeon Pyrococcus furiosus
por: Lobasso, Simona, et al.
Publicado: (2012)

Extracellular vesicles derived from tumour cells as a trigger of energy crisis in the skeletal muscle
por: Pin, Fabrizio, et al.
Publicado: (2021)

Mitochondria-Targeted Antioxidant SS-31 is a Potential Novel Ophthalmic Medication for Neuroprotection in Glaucoma
por: PANG, Yu, et al.
Publicado: (2015)

Targeting mitochondria in the aged cerebral vasculature with SS-31, a proteomic study of brain microvessels
por: Seman, Abigail, et al.
Publicado: (2023)

Haloferax volcanii, as a Novel Tool for Producing Mammalian Olfactory Receptors Embedded in Archaeal Lipid Bilayer
por: Lobasso, Simona, et al.
Publicado: (2015)

Peptide SS-31 upregulates frataxin expression and improves the quality of mitochondria: implications in the treatment of Friedreich ataxia
por: Zhao, Hongting, et al.
Publicado: (2017)

PGC1α overexpression preserves muscle mass and function in cisplatin‐induced cachexia
por: Huot, Joshua R., et al.
Publicado: (2022)

NAD(+) repletion with niacin counteracts cancer cachexia
por: Beltrà, Marc, et al.
Publicado: (2023)

Identification of unique cardiolipin and monolysocardiolipin species in Acinetobacter baumannii
por: Lopalco, Patrizia, et al.
Publicado: (2017)

Mitochondria-Targeted Antioxidant SS31 Prevents Amyloid Beta-Induced Mitochondrial Abnormalities and Synaptic Degeneration in Alzheimer’s Disease
por: Calkins, Marcus J., et al.
Publicado: (2012)

Mitochondria-Targeted Peptide SS31 Attenuates Renal Tubulointerstitial Injury via Inhibiting Mitochondrial Fission in Diabetic Mice
por: Yang, Shi-kun, et al.
Publicado: (2019)

Activation of Ca(2+)-dependent proteolysis in skeletal muscle and heart in cancer cachexia
por: Costelli, P, et al.
Publicado: (2001)

HCT116 colorectal liver metastases exacerbate muscle wasting in a mouse model for the study of colorectal cancer cachexia
por: Huot, Joshua R., et al.
Publicado: (2020)

Muscle NAD(+) depletion and Serpina3n as molecular determinants of murine cancer cachexia—the effects of blocking myostatin and activins
por: Hulmi, J.J., et al.
Publicado: (2020)

Elamipretide (SS-31) Ameliorates Isoflurane-Induced Long-Term Impairments of Mitochondrial Morphogenesis and Cognition in Developing Rats
por: Wu, Jing, et al.
Publicado: (2017)

Effect of the specific proteasome inhibitor bortezomib on cancer‐related muscle wasting
por: Penna, Fabio, et al.
Publicado: (2015)

Liquid Biopsy for Cancer Cachexia: Focus on Muscle-Derived microRNAs
por: Belli, Roberta, et al.
Publicado: (2021)

Amelioration of muscle wasting by gintonin in cancer cachexia
por: Wijaya, Yoseph Toni, et al.
Publicado: (2021)

Caspase 2 Activation and ER Stress Drive Rapid Jurkat Cell Apoptosis by Clofibrate
por: Penna, Fabio, et al.
Publicado: (2012)

SS31 Ameliorates age-related activation of NF-κB signaling in senile mice model, SAMP8
por: Hao, Zhi-Hua, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ij4giv1qf7emru6pddhc4vq62u